Supraventricular tachycardia shows up on an ECG as a fast, usually regular rhythm with narrow QRS complexes, meaning the electrical signal still travels through the heart’s normal conduction pathways even though it originates from an abnormal circuit above the ventricles. The heart rate typically exceeds 100 beats per minute at rest, but during an actual SVT episode it often runs much faster, sometimes well above 150. The ECG is the single most important tool for identifying SVT, sorting out which type of SVT is occurring, and ruling out the more dangerous look-alike, ventricular tachycardia. But reading SVT on an ECG is trickier than textbooks make it seem, and the specific pattern varies depending on the mechanism driving the arrhythmia.
What the ECG Actually Shows During an Episode
The hallmark of SVT on a standard 12-lead ECG is a rapid rhythm with a QRS duration under 120 milliseconds, which clinicians call a narrow-complex tachycardia. That narrow QRS tells you the ventricles are being activated through the normal His-Purkinje system rather than from an abnormal focus inside the ventricle itself. The rhythm is almost always regular, with each beat spaced evenly apart. Heart rates during SVT episodes commonly fall between 150 and 250 beats per minute in adults, which is fast enough that finding the P waves, the small deflections representing atrial activity, becomes the central challenge of ECG interpretation.
The initial evaluation focuses on three things: whether the rhythm is regular or irregular, how fast the rate is, and how wide the QRS complex looks. These three features alone narrow the possibilities considerably. A regular narrow-complex tachycardia at 150 beats per minute, for instance, should immediately raise suspicion for atrial flutter with 2:1 block, because the atrial rate in flutter is characteristically around 300 per minute and every other impulse gets through to the ventricles. An irregular narrow-complex tachycardia, meanwhile, points toward atrial fibrillation or multifocal atrial tachycardia rather than the classic reentrant forms of SVT.
Finding the P Waves
The P wave is where the real detective work happens. In a normal sinus rhythm, P waves sit upright in front of each QRS complex, clearly visible. During SVT, P waves can hide inside the QRS, appear just after it, sit between beats, or be completely buried and invisible. Where the P wave falls relative to the QRS complex tells you which circuit the electricity is running through, and that determines the specific SVT type.
In the most common form of SVT, called AVNRT (atrioventricular nodal reentrant tachycardia), the electrical impulse travels down a slow pathway and back up a fast pathway within the AV node. Because the atria and ventricles activate almost simultaneously, the retrograde P wave gets buried inside the QRS complex or just barely peeks out at the end of it. When it does peek out, it creates a small positive deflection at the tail end of the QRS in lead V1, often called a “pseudo r-prime” wave, or a small negative notch at the end of the QRS in the inferior leads (II, III, aVF), sometimes called a “pseudo S wave.” These subtle distortions are absent on the patient’s baseline ECG when they are in normal rhythm, and comparing the two tracings side by side is one of the most reliable ways to spot them.
Studies using radiofrequency catheter ablation as the gold standard have shown that the pseudo r-prime in V1 and the pseudo S wave in the inferior leads predict AVNRT with 100% specificity, though the sensitivity is more modest, around 55% for the pseudo r-prime and 20% for the pseudo S wave. In other words, when you see those features, you can be confident it is AVNRT, but their absence does not rule it out.
Short RP Versus Long RP Tachycardia
Once you have found the P wave, the next step is measuring where it falls between two QRS complexes. This is the RP interval concept, and it divides SVTs into two broad camps. If the P wave sits closer to the preceding QRS complex than to the next one, it is a “short RP” tachycardia. If the P wave sits closer to the following QRS, it is a “long RP” tachycardia.
Short RP tachycardias include typical AVNRT and orthodromic AVRT (atrioventricular reentrant tachycardia, the type that uses an accessory pathway like in Wolff-Parkinson-White syndrome). In both, ventricular activation comes first and atrial activation follows quickly, so the retrograde P wave appears shortly after the QRS. The RP interval in typical AVNRT is extremely short, often less than 70-90 milliseconds, while in orthodromic AVRT it tends to be a bit longer because the impulse has to travel retrograde through the accessory pathway, which takes extra time.
Long RP tachycardias include atypical AVNRT (where conduction follows the fast pathway down and the slow pathway up), a rare form of AVRT called permanent junctional reciprocating tachycardia (PJRT), and atrial tachycardia. In atrial tachycardia, the P wave originates from an abnormal focus in the atrium and conducts through the normal AV node pathway, so the P wave precedes each QRS much like it does in sinus rhythm, just at a faster rate and often with a different P wave shape.
A specialized lead placement called the Lewis lead can help when P waves are hard to see on the standard ECG. This technique uses a bipolar chest lead configuration that amplifies atrial electrical activity. Research has found that the RP interval measured on a Lewis lead is significantly longer in AVRT than in typical AVNRT, and using a cutoff of 100 milliseconds can distinguish the two with about 89% sensitivity and 71% specificity.
When the QRS Is Wide
SVT does not always produce a narrow QRS. When the electrical signal encounters a delay in one of the bundle branches, or when there is a pre-existing bundle branch block, the QRS widens beyond 120 milliseconds. This creates a wide-complex tachycardia (WCT) that looks alarmingly similar to ventricular tachycardia (VT) on the ECG. The distinction matters enormously because the treatment and prognosis differ: VT can be life-threatening and often requires immediate defibrillation, while SVT with a wide QRS (called SVT with aberrancy) is usually manageable with medications that target the AV node.
Several ECG-based algorithms have been developed to sort out this problem. A systematic review and meta-analysis comparing the major algorithms found that their sensitivity for detecting VT ranged from about 78% to 95%, with specificity ranging from roughly 60% to 88%. The Vereckei “pre” algorithm, which uses a four-step analysis of the full 12-lead ECG, showed the highest overall diagnostic accuracy. A later simplified version by the same group uses only lead aVR and was found to have accuracy superior to the earlier Brugada algorithm, with better sensitivity for VT and better specificity for SVT.
Even with these algorithms, about one in ten wide-complex tachycardias gets misclassified or remains ambiguous on the surface ECG alone. One important practical point: using a modified chest lead (MCL1) instead of the true V1 lead produced a clearly different QRS shape in about 40% of VT cases, making it diagnostically inferior. If you only have a single-lead monitor rather than a full 12-lead, the tracing should be interpreted with extra caution.
How Adenosine Helps Decode the ECG
Adenosine is both a treatment and a diagnostic tool in SVT. Given as a rapid intravenous push, it temporarily blocks conduction through the AV node for a few seconds. The response to adenosine reveals which part of the heart the arrhythmia depends on.
If the tachycardia terminates abruptly after adenosine, the circuit was using the AV node as a critical link, which means it was either AVNRT or AVRT. If the tachycardia continues but you can suddenly see flutter waves or abnormal P waves on the ECG while the ventricular rate slows, the rhythm was atrial flutter or atrial tachycardia, and the AV node was just an innocent bystander passing impulses through. This “unmasking” of atrial activity is one of the most valuable diagnostic maneuvers in acute cardiology, because atrial flutter with 2:1 conduction can look deceptively like a simple SVT on the surface ECG.
Distinguishing atrial tachycardia from atrial flutter on the surface ECG without adenosine is sometimes possible by looking at the P wave morphology, the baseline between beats, the regularity of R-R intervals, and the cycle length, but the overlap between the two can be subtle enough that adenosine or an invasive electrophysiology study is needed to settle the question.
SVT in Children Versus Adults
The ECG appearance of SVT differs somewhat in children, partly because of the faster baseline heart rates in young patients and partly because the dominant SVT mechanism changes with age. In infants, SVT typically produces heart rates between 220 and 320 beats per minute, while in older children rates tend to fall between 160 and 280 beats per minute. The most common SVT mechanism in newborns and infants is AVRT involving an accessory pathway, while in adolescents and adults AVNRT takes over as the most common form. Focal atrial tachycardia accounts for roughly 10-15% of pediatric SVTs across all age groups.
These age-related differences mean the ECG clues are weighted differently. In an infant with SVT at 280 beats per minute, the very fast rate makes P waves nearly impossible to see, and the differential often comes down to comparing the ECG during the episode with a baseline tracing, looking for signs of pre-excitation (a delta wave suggesting an accessory pathway) once the rhythm converts back to normal. Because accessory pathway-mediated tachycardias are more common in very young children, clinicians are more alert to AVRT patterns in this age group than they would be in an adult presenting with the same rate.
What Happens to the ECG After SVT Stops
One of the more unsettling aspects of SVT is what the ECG can look like after the episode ends. Patients sometimes develop ST segment depression or even ST elevation on their post-conversion tracing, mimicking the pattern seen during a heart attack. These changes can persist for minutes to hours after the rhythm has returned to normal, and they generate understandable alarm.
Case reports have documented obvious ST depression across most leads in patients who converted from SVT to sinus rhythm, even in the absence of any coronary artery disease. The mechanism is thought to be related to the high metabolic demands placed on the heart during the rapid rate, creating a temporary mismatch between oxygen supply and demand. The key clinical point is that these post-SVT ST changes do not automatically mean the patient is having a myocardial infarction, but they do need to be taken seriously and evaluated in context, particularly if the patient has risk factors for coronary disease or ongoing chest pain.
Smartwatches and Single-Lead ECGs
Consumer wearable devices that record single-lead ECGs have created a new frontier for SVT detection. In theory, a smartwatch could capture an episode in progress, something the standard 12-lead ECG in a clinic often misses because the arrhythmia may have stopped by the time the patient arrives. In practice, the diagnostic accuracy of these single-lead recordings is decent but not as reliable as the full 12-lead.
A study comparing Apple Watch single-lead ECGs with findings from invasive electrophysiology studies found that physicians interpreting the smartwatch tracings achieved accuracy rates in the range of 66 to 77%, with only moderate agreement between different readers. By contrast, the standard 12-lead ECG had nearly perfect sensitivity and specificity. A separate prospective study found that when electrophysiologists reviewed smartphone-based single-lead ECGs, they could distinguish SVT from inappropriate sinus tachycardia with about 89% sensitivity and 91% specificity. When only high-quality recordings were included, sensitivity climbed to 95%.
The practical message is that a smartwatch tracing showing a fast regular rhythm is useful, and bringing it to your doctor can be genuinely helpful for diagnosis, particularly if your episodes are short-lived and hard to catch on a traditional monitor. But a single-lead recording has real limitations: it cannot provide the multi-angle view needed to classify the SVT subtype or confidently rule out VT. Think of it as a good screening tool that can speed up the path to a definitive diagnosis, not as a replacement for the full ECG.
ECG Artifacts That Mimic SVT
Not everything that looks like SVT on the ECG actually is SVT. Electrical interference and patient movement can produce artifacts that closely resemble arrhythmias. Limb movement during recording causes sudden irregularities in the ECG baseline that can look like premature beats or even sustained supraventricular or ventricular arrhythmias. Tremor from Parkinson’s disease or shivering is a classic offender, producing a fine, irregular baseline that can be mistaken for atrial fibrillation or flutter.
Electrode issues are another common source of false alarms. A loose lead or dried-out electrode gel can generate a wandering baseline or intermittent spikes that mimic ectopic beats. In the era of wearable monitors, where recordings happen during daily activity rather than in a quiet clinic, artifact rates are higher than with traditional supervised ECGs. When reviewing any ECG that raises suspicion for SVT, it is worth checking whether the QRS complexes themselves are consistent in shape and timing. True arrhythmias produce organized, repeating electrical patterns. Artifact tends to be chaotic and does not respect the normal timing relationships between ECG waves.
The Vagal Maneuver Response as a Diagnostic Clue
Before any medication reaches the patient, clinicians often try vagal maneuvers as a first step. The Valsalva maneuver, where the patient bears down as though straining, increases vagal tone to the AV node and can terminate AV node-dependent tachycardias. It is considered the most effective vagal technique available and is recommended as the first-line treatment in hemodynamically stable patients, though its success rate for converting SVT is relatively low when performed in the standard way.
The response to vagal maneuvers carries diagnostic information much like the response to adenosine. If the tachycardia abruptly stops, it was almost certainly AVNRT or AVRT, both of which depend on the AV node. If the rate slows transiently and then speeds back up once the maneuver is released, or if the rhythm does not change at all, atrial tachycardia or atrial flutter becomes more likely. Watching the ECG monitor during a vagal maneuver is therefore both a treatment attempt and a diagnostic test rolled into one. When it works, you have both terminated the arrhythmia and identified the mechanism. When it fails, you still learn something about what you are dealing with.
Why the Baseline ECG Matters
One of the most underappreciated aspects of SVT diagnosis is the value of having a baseline ECG taken when the patient is in normal sinus rhythm. Many of the ECG clues described above rely on comparison. The pseudo r-prime in V1 during AVNRT is only meaningful if it was not present at baseline. A delta wave suggesting Wolff-Parkinson-White pattern is only visible when the patient is in sinus rhythm, not during the tachycardia itself (during orthodromic AVRT, the QRS typically looks normal because conduction is going down through the AV node). ST changes after SVT termination are only alarming if you know what the patient’s baseline ST segments looked like.
For people who have recurrent episodes of SVT, keeping a copy of a baseline 12-lead ECG on your phone or in your wallet is a genuinely practical step. When you show up in an emergency department during or after an episode, having that comparison tracing available can save time and reduce unnecessary testing. It also helps the emergency physician distinguish SVT-related post-conversion changes from a real acute coronary syndrome, potentially avoiding an unnecessary cardiac catheterization.
When the Surface ECG Is Not Enough
For all its utility, the surface ECG has limits. Some SVT episodes are too brief to catch, some produce ambiguous patterns, and some can only be definitively classified by recording electrical signals from inside the heart during an electrophysiology study. In that procedure, catheters are threaded into the heart through a vein, and precise measurements of conduction timing reveal exactly which circuit is responsible. The same procedure also allows catheter ablation, a curative treatment for most SVT types.
The gap between what the surface ECG can tell you and what an invasive study reveals is most significant in the overlap zone between AVNRT and AVRT with a concealed accessory pathway. Both can produce nearly identical narrow-complex, short-RP tachycardias on the 12-lead ECG. While certain subtle features like the pseudo r-prime in V1 lean toward AVNRT, many tracings simply do not provide enough information to tell the two apart. In clinical practice, this ambiguity often does not matter for acute management, because the same drugs (adenosine, calcium channel blockers) work for both. It matters more for long-term planning, because the ablation target is different for each, and knowing the mechanism in advance helps the electrophysiologist prepare.